Print

Print


Mr. Charters:

Your efforts in putting together all of these websites is most commendable -
and useful.

It is interesting that the data presented in all of those sites is the data
of Dr. Olivier Rascol, professor of pharmacology at the Centre Hospitalier
Universitaire, Toulouse, France.

He has been working on that data obviously since 1996, when he presented the
six month results at the American Academy as "preliminary results."  The
same data has been presented at the American Academy in 1998 and in 2000, as
well as in the International Congress of Neurology.  IT IS THE SAME STUDY -
only one study.

That study has been published and republished and republished - all under
the auspices of Smith Kline Beecham.

The facts speak for themselves.

Jorge Romero, MD

----- Original Message -----
From: "Murray Charters" <[log in to unmask]>
To: <[log in to unmask]>
Sent: Sunday, June 04, 2000 10:55 AM
Subject: Requip Links Was: Re: question for Paul Lauer


Hi All,
The five-year study of the incidence of dyskinesia in patients with early
Parkinson's disease who
were treated with ropinirole or levodopa should be viewed in the proper
light if you recognize its very narrow focus... "incidence of dyskinesia"
and
don't try to read anything else into it.... This report was on one aspect
only.

Here is another narrow focus deliberately taken out of context as a
contrast.
"CNS adverse experiences were reported by 23% of patients given ReQuip®
and by 16% of those who received L-dopa"

What does it tell you?  (the jury is out, listen to your health
professional,
don't attempt to self prescribe, don't put too much emphasis on any single
study, etc.)

Here are some requip / ropinerole links...

Requip (Ropinirole) Safely Manages Parkinson's Symptoms Long-term
PHILADELPHIA, PA -- May 18, 2000
http://www.pslgroup.com/dg/1d25aa.htm

Search Dr. Guide Email Edition for Ropinerole
http://www.docguide.com/dg.nsf/searchall/?searchview&query=%5BDocBody%5DCONT
AINS(%
22Ropinirole%22)&SearchOrder=1&SearchMax=50&m=exact

Search Dr. Guide for SmithKline+Beecham
http://www.docguide.com/dg.nsf/searchall/?searchview&query=%5BDocBody%5DCONT
AINS(%
22SmithKline+Beecham%22)&SearchOrder=1&SearchMax=50&m=exact

The New England Journal of Medicine
http://www.nejm.org/content/index.asp
http://www.nejm.org/content/2000/0342/0020/1484.asp

PubMed
http://www.ncbi.nlm.nih.gov/PubMed/
Search on Rascol
A five-year study of the incidence of dyskinesia in patients with early
Parkinson's disease who
were treated with ropinirole or levodopa. 056 Study Group.
N Engl J Med. 2000 May 18;342(20):1484-91.
(A click on related articles gives you hundreds of abstracts to browse)

ReQuip® cuts risk of dyskinesias by 15-fold in early Parkinson's disease
http://www.eurekalert.org/releases/medit-rcr071999.html

Ropinirole Relieves Symptoms of Early Parkinson's Disease
http://www.docguide.com/dg.nsf/PrintPrint/1D585B2EB14DC29F852562FA005C8A2C

Parkinson's Disease: New Treatment Options
http://www.infomed.org/pharma-kritik-e/abs1719.html

Requip (ropinirole hydrochloride, SmithKline Beecham) is an effective
treatment for early stage Parkinson's disease
http://pharminfo.com/drugpr/requip_pr.html

ReQuip More Effective Against Dyskinesia Than L-dopa
http://www.pslgroup.com/dg/11a766.htm

SmithKline Beecham Parkinson's Disease Press Release - 1/13/98
http://www.druginfonet.com/park2.htm

Links to Web sites are provided for information purposes. I assume no
responsibility or liability for material on linked sites. Please be
advised: Medical information should always be reviewed with your physician
or attending professional before attempting to change any medication or
therapy. Be forewarned... you must never assume that information obtained
from the web is
necessarily the best information available (or even valid).
Remember, no one sets content rules on the Internet.

That said, there is an education awaiting you!

Starting here...
Surfer Beware
http://www.cmdg.org/Surfer_Warning/surfer_warning.htm

FDA Consumer Health Information On-Line "Is This Site Reliable?"
http://www.fda.gov/fdac/features/596_info.html

We can make a difference ......... murray
[log in to unmask]

View the Parkinson's Awareness Links at:
http://www.geocities.com/janet313/pienet/wwweb/index.html